Skip to content

ORKA

Oruka Therapeutics, Inc.

Stock

$84.52+1.10 (+1.32%)Close Oct 2, 2026

Shareholders' equity, 2025
$472M
5-year CAGR
+58.9%
10-year CAGR
+28.6%

Shareholders' equity

Shareholders' equity by fiscal year

PeriodEquityYoY
2025$472M—
2023$37M−11.2%
2022$42M−18.4%
2021$51M+9.7%
2020$47M+511.3%
2019$7.6M+26.2%
2018$6.0M−41.3%
2017$10M−53.7%
2016$22M−41.7%
2015$38M+158.3%
2014$15M−5.4%
2013$16M+436.0%
2012$2.9M−49.3%
2011$5.7M−15.3%
2010$6.8M−8.6%
2009$7.4M—
2008−$38M—
2007−$20M—
2006−$5.7M—
2005−$678K—
2004−$619K—